|
Company:
|
GRIFOLS SA (GRFS)
|
|
Form Type:
|
6-K
|
|
Filing Date:
|
12/2/2011
|
|
CIK:
|
0001438569
|
|
Address:
|
1585 BROADWAY
SUITE 2376
|
|
City, State, Zip:
|
NEW YORK, New York 10036
|
|
Telephone:
|
212-969-3335
|
|
|
|
|
|
Last Trade
|
Last Trade:
$20.12
|
Change:
-0.16 (-0.79%)
|
Trade Time:
Aug 18
|
Market Cap:
$5.26B
|
|
|
|
|
|
|
Description of Business
|
|
We were founded in 1940 in Barcelona, Spain by Dr. José Antonio Grifols i Roig,
a specialist and pioneer in blood transfusions and clinical analysis and the
grandfather of our current Chairman of the Board. We have been making and
selling plasma derivative products for more than 70 years. Over the last 25
years, we have grown from a predominantly domestic Spanish company into a global
company by expanding both organically and through acquisitions throughout
Europe, the United States, Latin America and Asia.
We were incorporated in Spain as a limited liability company on June 22, 1987
under the name Grupo Grifols, S.A., and we changed our name to Grifols, S.A. in
2005. We conduct business under the commercial name "Grifols." Our principal
executive office is located at Avinguda de la Generalitat, 152 Parque
Empresarial Can Sant Joan, 08174 Sant Cugat del Vallès, Barcelona, Spain and our
telephone number is +34 93 571 0500.
|
|
|
|